Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity
about
Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune TargetsMinor histocompatibility antigens and the maternal immune response to the fetus during pregnancyIdentification of minor histocompatibility antigens based on the 1000 Genomes ProjectWhole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation.Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantationMicroarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies.Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCTDurable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.Minor histocompatibility antigens: past, present, and future.Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives.Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.
P2860
Q26750999-6FD3D319-586F-42BD-AC62-340DB35BAA65Q33723635-E41F8FD9-738F-4914-BB3F-E44F0989A5FDQ34648976-905253D6-1641-4805-B9F0-0AE82FBD8C91Q35153382-A6FD319C-69BC-4E8B-A0E6-0B810D8CC222Q35588845-D5215B45-64DE-49DD-B5B3-3C97834F6906Q36015721-05AE611E-CBB4-4FDF-86CD-7F14DC4A0E2BQ36305321-B7E1D4F4-FD83-421D-AFC9-802F67AA34D8Q37484001-4214A610-86D5-4EF1-8BC1-6282D2B49B92Q38216836-E1111235-48AC-4BCA-AE78-290C5ED2119FQ38254976-E0BF086A-822F-4232-883D-DCCE62734A94Q38616461-657293DD-26BB-4FB3-B6A8-57BB81FDEAD7Q42084183-86F4D794-DA2A-4482-8BA9-E4F97D6F550FQ43234209-6DC98676-F528-44BB-BD56-34F05F5EE51A
P2860
Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@ast
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@en
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@nl
type
label
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@ast
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@en
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@nl
prefLabel
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@ast
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@en
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@nl
P2093
P2860
P1433
P1476
Identification of 4 novel HLA- ...... aft-versus-leukemia reactivity
@en
P2093
Edith D van der Meijden
Ellie G A Lurvink
J H Frederik Falkenburg
M Willy Honders
Michel G D Kester
Simone A P van Luxemburg-Heijs
P2860
P304
P356
10.3324/HAEMATOL.2011.049478
P577
2012-03-14T00:00:00Z